4516 logo

Nippon Shinyaku Co., Ltd. Stock Price

TSE:4516 Community·JP¥242.8b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 1 Fair Values set on narratives written by author

4516 Share Price Performance

JP¥0
-4113.00 (-100.00%)
JP¥0
-4113.00 (-100.00%)
Price JP¥0

4516 Community Narratives

There are no narratives available yet.

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Flawless balance sheet with solid track record and pays a dividend.

2 Risks
3 Rewards

Nippon Shinyaku Co., Ltd. Key Details

JP¥160.5b

Revenue

JP¥51.5b

Cost of Revenue

JP¥109.0b

Gross Profit

JP¥77.1b

Other Expenses

JP¥31.9b

Earnings

Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
Feb 09, 2026
473.95
67.91%
19.90%
0%
View Full Analysis

About 4516

Founded
1911
Employees
2243
CEO
Toru Nakai
WebsiteView website
www.nippon-shinyaku.co.jp

Nippon Shinyaku Co., Ltd. manufactures and sells pharmaceuticals and foodstuffs in Japan and internationally. The company operates through Pharmaceuticals and Functional Food Business segments. It offers drugs in the fields of urology, hematology, intractable and rare diseases, gynecology, and other diseases; health food ingredients, preservatives, protein preparations, and supplements. The company in the Strategic Partnership with Nippon Shinyaku to develop ATSN-10 that is in Phase I/II of clinical trials for the treatment of GUCY2D-mutant Leber congenital amaurosis; and RGX-121 for the treatment of mucopolysaccharidosis. Nippon Shinyaku Co., Ltd. was founded in 1911 and is headquartered in Kyoto, Japan.

Recent 4516 News & Updates

Nippon Shinyaku (TSE:4516) Has Affirmed Its Dividend Of ¥62.00

Sep 25
Nippon Shinyaku (TSE:4516) Has Affirmed Its Dividend Of ¥62.00

Recent updates

No updates